1997, Guangzhou Nanxin Pharmaceutical Co., Ltd. obtained the GMP certification of China, and was the first batch of enterprises that passed the national GMP certification, with an annual output of 5 million bottles of infusion, 75 million tablets and capsules, 2 million bottles of children's dry suspension and 5 million injections.
In 2005, India's Ranbaxy Company invested and established a "Technology Development Laboratory" (TDL) in Guangzhou Nanxin Factory to speed up the production of new products. Nanxin Company has listed and registered 53 drugs, including 10 national essential drugs, two separately priced products and Lamborghini patented product "Cifrafranod".
20 10 Hunan nonferrous metals group, a subsidiary of China Minmetals, acquired Guangzhou Nanxin, which brought new opportunities for the development of Nanxin. With the close cooperation with the National Academy of Military Medical Sciences, a batch of original research and first imitation drugs will be listed soon.